Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02611739
Other study ID # 1000049494
Secondary ID
Status Completed
Phase N/A
First received November 19, 2015
Last updated December 29, 2017
Start date January 2016
Est. completion date December 2016

Study information

Verified date December 2017
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pain is a frequent and significant problem related to cancer-directed treatment in children. Children with cancer often cite needle procedures as the most distressing experience caused by cancer and its treatment. Recently it has been shown that an interactive humanoid robot is capable of facilitating distraction and reducing distress during childhood immunizations. Our research objectives are to: (1) assess the feasibility of implementing the robot (Medi-Port) for effectiveness testing in a future RCT (measured as implementation outcomes) and (2) determine treatment effectiveness estimates (measured as preliminary effectiveness outcomes), compared to standard medical care.


Description:

A sample of 40 children with cancer between the ages of 4-9 years (20 participants per treatment arm; 10 boys and 10 girls per treatment arm) will be recruited. The feasibility of the trial protocol to evaluate the impact of distraction via the humanoid robot on pain intensity and distress during SCP needle insertion compared to an active control in children with cancer will be explored. The effectiveness outcome includes the examination of the robot programmed to distract children during the procedure, reduce pain intensity and distress compared to an active control intervention (i.e. dancing robot).


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 4 Years to 9 Years
Eligibility Inclusion Criteria:

- 4-9 years

- able to speak and understand English,

- actively undergoing cancer treatment

- presenting to clinic for at least a 2nd subcutaneous port needle insertion

- being at least 1 month from diagnosis.

Exclusion Criteria:

- visual, auditory or cognitive impairments precluding interaction with Medi-Port

- end-of-life patients

- patients who are nil per os pre-sedation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Medi-Port
Treatment
Medi-Port
Control

Locations

Country Name City State
Canada Hospital for Sick Children Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
The Hospital for Sick Children University of Calgary

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accrual rates Accrual rates will be captured by recording data related to the number of eligible children per recruitment day, reasons for ineligibility, and reasons for non-participation. 12 months
Primary Acceptability Acceptability will be measured using the Medi-Port Satisfaction Questionnaire completed by children, parent, and nurses that will collect data on acceptability, perceived utility of pain reducing procedures, and recommendations for changes related to the needle insertion experience. 12 months
Primary Outcome measure feasibility Outcome measure feasibility will be measured as the percentage of completed outcome measures at baseline and study completion (100% when all questionnaires are completed) and will be recorded on Medi-Port Activity Log. 12 months
Primary Technical difficulties Technical difficulties (occurrence and description) will be captured using the Medi-Port Intervention Log, designed to record data. 12 months
Primary Practical difficulties Practical difficulties will be captured using the Medi-Port Intervention Log, designed to record data. 12 months
Primary Time Practical difficulties will be captured using the Medi-Port Intervention Log, designed to record data. 12 months
Secondary Pain intensity Pain intensity (both retrospectively for previous SCP access and after the study procedures) will be measured. Children will self-report their pain and parents, nurses, and the researcher will use proxy-reporting in rating children's pain. Children will use the Faces Pain Scale-Revised (FPS-R) which has been validated in children 4 years and older. Parents, nurses, and the researcher will use an 11-point numerical rating scale (NRS), with verbal anchors of "no pain at all" at 0 and "the most pain you can imagine this child having" at 10. 12 months
Secondary Distress Distress (both retrospectively for previous SCP access and after the study procedures will be measured). Children will retrospectively report fear using the Children's Fear Scale (CFS), which is a visual scale with established psychometrics in children 5-10 years. Parents will retrospectively report pain using an 11-point NRS. Distress during the study SCP access will be measured using the observer-rated Behavioral Approach-Avoidance Scale (BAADS). The same 2 trained research team members will code video-recordings from all SCP needle insertions using the BAADS. Child distress behaviours will be scored at specific steps during the procedure: 1) nurse movement towards the child 2) pre-procedure skin sterilization 3) SCP position assessment by nurse 4) needle insertion 5) sterile dressing application. 12 months